Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line

Journal of Cell Communication and Signaling

Volumn 7, Issue 2, 2013, Pages 151-160

  Begandt, Daniela ^a   Bader, Almke ^a   Dreyer, Lutz ^a   Eisert, Natalie ^a   Reeck, Thilo ^a   Ngezahayo, Anaclet ^a,b  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

cAMP; Dipyridamole; Gap junction; PKA; Vascular smooth muscle cells

Indexed keywords

8 BROMO CYCLIC AMP; CYCLIC AMP; DIPYRIDAMOLE; FORSKOLIN; GAP JUNCTION PROTEIN; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; GAP JUNCTION; NONHUMAN; OSCILLATORY POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; VASCULAR SMOOTH MUSCLE;

BOVINAE; RATTUS;

EID: 84878752764     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-013-0196-4     Document Type: Article

References (51)

1. Abudara V, Eyzaguirre C, Saez JC (2000) Short- and long-term regulation of rat carotid body gap junctions by cAMP. Identification of connexin43, a gap junction subunit. Adv Exp Med Biol 475:359-369
2. Alheid U, Reichwehr I, Forstermann U (1989) Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP. Eur J Pharmacol 164(1):103-110
3. Anfossi G, Russo I, Massucco P, Mattiello L, Cavalot F, Balbo A, Trovati M (2002) Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. Thromb Res 105(1):71-78
4. Atkinson MM, Lampe PD, Lin HH, Kollander R, Li XR, Kiang DT (1995) Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells. J Cell Sci 108(Pt 9):3079-3090
5. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280(16):15880-15887
6. Begandt D, Bintig W, Oberheide K, Schlie S, Ngezahayo A (2010) Dipyridamole increases gap junction coupling in bovine GM-7373 aortic endothelial cells by a cAMP-protein kinase A dependent pathway. J BioenergBiomembr 42(1):79-84
7. Brisset AC, Isakson BE, Kwak BR (2009) Connexins in vascular physiology and pathology. Antioxid Redox Signal 11(2):267-282
8. Burghardt RC, Barhoumi R, Sewall TC, Bowen JA (1995) Cyclic AMP induces rapid increases in gap junction permeability and changes in the cellular distribution of connexin43. J Membr Biol 148(3):243-253
9. Chadjichristos CE, Kwak BR (2007) Connexins: new genes in atherosclerosis. Ann Med 39(6):402-411
10. Cruciani V, Mikalsen SO (2002) Connexins, gap junctional intercellular communication and kinases. Biol Cell 94(7-8):433-443
11. de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U (2000) Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 86(6):649-655
12. de Wit C, Roos F, Bolz SS, Pohl U (2003) Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics 13(2):169-177
13. de Wit C, Hoepfl B, Wolfle SE (2006) Endothelial mediators and communication through vascular gap junctions. Biol Chem 387(1):3-9
14. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A (1996) European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143(1-2):1-13
15. Eisert WG (2006) Dipyridamole. In: Michelson AD (ed) Platelets, 2 edn. Amsterdam, pp 1165-1179
16. el-Fouly MH, Trosko JE, Chang CC (1987) Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 168(2):422-430
17. ESPRIT Study Group, Halkes PH, van Gijn J, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. 2006 May; 367, 9523, pp 1665-73
18. Figueroa XF, Duling BR (2009) Gap junctions in the control of vascular function. Antioxid Redox Signal 11(2):251-266
19. Figueroa XF, Isakson BE, Duling BR (2004) Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) 19:277-284
20. Figueroa XF, Isakson BE, Duling BR (2006) Vascular gap junctions in hypertension. Hypertension 48(5):804-811
21. Haefliger JA, Meda P (2000) Chronic hypertension alters the expression of Cx43 in cardiovascular muscle cells. Braz J Med Biol Res 33(4):431-438
22. Haefliger JA, Meda P, Formenton A, Wiesel P, Zanchi A, Brunner HR, Nicod P, Hayoz D (1999) Aortic connexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase. Arterioscler Thromb Vasc Biol 19(7):1615-1622
23. Haefliger JA, Nicod P, Meda P (2004) Contribution of connexins to the function of the vascular wall. Cardiovasc Res 62(2):345-356
24. Harris AL (2001) Emerging issues of connexin channels: biophysics fills the gap. Q Rev Biophys 34(3):325-472
25. He DS, Jiang JX, Taffet SM, Burt JM (1999) Formation of heteromeric gap junction channels by connexins 40 and 43 in vascular smooth muscle cells. Proc Natl Acad Sci U S A 96(11):6495-6500
26. Hoffmann A, Gloe T, Pohl U, Zahler S (2003) Nitric oxide enhances de novo formation of endothelial gap junctions. Cardiovasc Res 60(2):421-430
27. Holm I, Mikhailov A, Jillson T, Rose B (1999) Dynamics of gap junctions observed in living cells with connexin43-GFP chimeric protein. Eur J Cell Biol 78(12):856-866
28. Jobs A, Schmidt K, Schmidt VJ, Lübkemeier I, van Veen TA, Kurtz A, Willecke K, de Wit C (2012) Defective Cx40 maintains Cx37 expression but intact Cx40 is crucial for conducted dilations irrespective of hypertension. Hypertension 60(6):1422-1429
29. Kim HH, Liao JK (2008) Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol 28(3):s39-s42
30. Lampe PD, Lau AF (2004) The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36(7):1171-1186
31. Levin M, Mercola M (1998) Gap junctions are involved in the early generation of left-right asymmetry. Dev Biol 203(1):90-105
32. Liao Y, Day KH, Damon DN, Duling BR (2001) Endothelial cell-specific knockout of connexin 43 causes hypotension and bradycardia in mice. Proc Natl Acad Sci U S A 98(17):9989-9994
33. Molina-Arcas M, Casado FJ, Pastor-Anglada M (2009) Nucleoside transporter proteins. Curr Vasc Pharmacol 7(4):426-434
34. Mundell SJ, Kelly E (1998) The effect of inhibitors of receptor internalization on the desensitization and resensitization of three Gs-coupled receptor responses. Br J Pharmacol 125(7):1594-1600
35. Mundell S, Kelly E (2011) Adenosine receptor desensitization and trafficking. Biochim Biophys Acta 1808(5):1319-1328
36. Nicholson SM, Bruzzone R (1997) Gap junctions: getting the message through. Curr Biol 7(6):R340-R344
37. Paulson AF, Lampe PD, Meyer RA, TenBroek EM, Atkinson MM, Walseth TF, Johnson RG (2000) Cyclic AMP and LDL trigger a rapid enhancement in gap junction assembly through a stimulation of connexin trafficking. J Cell Sci 113(Pt 17):3037-3049
38. Podgorska M, Kocbuch K, Pawelczyk T (2005) Recent advances in studies on biochemical and structural properties of equilibrative and concentrative nucleoside transporters. Acta Biochim Pol 52(4):749-758
39. Popp R, Brandes RP, Ott G, Busse R, Fleming I (2002) Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ Res 90(7):800-806
40. Sands WA, Palmer TM (2008) Regulating gene transcription in response to cyclic AMP elevation. Cell Signal 20(3):460-466
41. Schmidt VJ, Wolfle SE, Boettcher M, de Wit C (2008) Gap junctions synchronize vascular tone within the microcirculation. Pharmacol Rep 60(1):68-74
42. Schmidt VJ, Jobs A, von Maltzahn J, Wörsdörfer P, Willecke K, de Wit C (2012) Connexin45 is expressed in vascular smooth muscle but its function remains elusive. PLoS One 7(7):e42287. doi: 10.1371
43. Simon AM, McWhorter AR (2002) Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251(2):206-220
44. Solan JL, Lampe PD (2009) Connexin43 phosphorylation: structural changes and biological effects. Biochem J 419(2):261-272
45. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N (2005) Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res 97(7):655-662
46. TenBroek EM, Lampe PD, Solan JL, Reynhout JK, Johnson RG (2001) Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J Cell Biol 155(7):1307-1318
47. van Rijen HV, van Veen TA, Hermans MM, Jongsma HJ (2000) Human connexin40 gap junction channels are modulated by cAMP. Cardiovasc Res 45(4):941-951
48. Visser F, Vickers MF, Ng AM, Baldwin SA, Young JD, Cass CE (2002) Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem 277(1):395-401
49. Wagner C, de Wit C, Kurtz L, Grünberger C, Kurtz A, Schweda F (2007) Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res 100(4):556-563
50. Wagner C, Jobs A, Schweda F, Kurtz L, Kurt B, Lopez ML, Gomez RA, van Veen TA, de Wit C, Kurtz A (2010) Selective deletion of Connexin 40 in renin-producing cells impairs renal baroreceptor function and is associated with arterial hypertension. Kidney Int 78(8):762-768
51. Yogo K, Ogawa T, Akiyama M, Ishida N, Takeya T (2002) Identification and functional analysis of novel phosphorylation sites in Cx43 in rat primary granulosa cells. FEBS Lett 531(2):132-136